000 -LEADER |
fixed length control field |
02250cam a22002774a 4500 |
001 - CONTROL NUMBER |
control field |
vtls003228026 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
MY-SjTCS |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20200306165943.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
111213s2010 nyua b 001 0 eng |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9781607418306 (hbk.) |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
1607418304 (hbk.) |
039 #9 - LEVEL OF BIBLIOGRAPHIC CONTROL AND CODING DETAIL [OBSOLETE] |
Level of rules in bibliographic description |
201203141528 |
Level of effort used to assign nonsubject heading access points |
shuhada |
Level of effort used to assign subject headings |
201203141524 |
Level of effort used to assign classification |
shuhada |
Level of effort used to assign subject headings |
201202211607 |
Level of effort used to assign classification |
izani |
-- |
201112131430 |
-- |
malathy |
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
615.7 |
Item number |
BIO 2010 |
245 00 - TITLE STATEMENT |
Title |
Biopharmaceutics and drug hypersensitivity / |
Statement of responsibility, etc. |
Paul Mossillo and John Pinzini, editors. |
260 ## - PUBLICATION, DISTRIBUTION, ETC. |
Place of publication, distribution, etc. |
New York : |
Name of publisher, distributor, etc. |
Nova Science Publishers, |
Date of publication, distribution, etc. |
c2010. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
xiv, 267 p. : |
Other physical details |
ill. (some col.) ; |
Dimensions |
24 cm. |
490 1# - SERIES STATEMENT |
Series statement |
Pharmacology-research, safety testing and regulation series |
504 ## - BIBLIOGRAPHY, ETC. NOTE |
Bibliography, etc. note |
Includes bibliographical references and index. |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
Bioequivalence : some relevant clinical and biopharmaceutic aspects / Francisco J. Flores-Murrieta ... [et al.] -- Advances in drug discovery to assess cholinergic neurotransmission / David R. da Rocha ... [et al.] -- Method suitability for models of intestinal drug permeability / Donna A. Volpe -- Stevens-Johnson syndrome with ocular complication / Mayumi Ueta -- Prophylactic effect of rescalmin, an antiallergic agent, against hypersensitivity reactions to anticancer drugs : paclitaxel and beyond / Shinji Sasada -- Pharmacopoeial quality of antimicrobial and antiviral formulations from former Soviet Union republics : focus on aciclovir / Andres Meos and Vallo Matto -- The interaction of the prion protein with triazine-based biomimetic affinity ligands / Giannis Mavridis and Nikolaos E. Labrou -- Downstream processing strategies for the purification of recombinant proteins from transgenic maize : chromatographic evaluation of the synthetic affinity ligand 4-amino-phenyl-oxanilic acid / Dimitris Platis and Nikolaos E. Labrou -- A critical approach to an allergic paradox : allergic and allergic-like reactions to glucocorticoids : delayed hypersensitivity mechanisms / M.T. Ventura ... [et al.]. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Biopharmaceutics. |
9 (RLIN) |
275895 |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Drug allergy. |
9 (RLIN) |
58486 |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Mossillo, Paul. |
9 (RLIN) |
58487 |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Pinzini, John. |
9 (RLIN) |
58488 |
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE |
Uniform title |
Pharmacology--research, safety testing and regulation series. |
9 (RLIN) |
59642 |
920 ## - Programme |
Programme |
PHA : 177875 |
999 ## - SYSTEM CONTROL NUMBERS (KOHA) |
Koha biblionumber |
59231 |
Koha biblioitemnumber |
59231 |